Online Only Articles

Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis

Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain
Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain
Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain
Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain
Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain
Sección de Oncohematología Pediátrica, Hospital Virgen de Arrixaca, Murcia, Spain
Servicio de Hematología, Hospital Clínico San Carlos, IdISSC, Medicina UCM, Madrid, Spain
Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain
Hematology Department, ICO-Hospital Germans Trias i Pujol and Josep Carreras Leukemia Research Institute, Barcelona, Spain
Servicio de Hematología, Hospital de la Santa Creu i Sant Pau and Josep Carreras Leukemia Research Institute, Barcelona, Spain
Department of Medicine and Program of Excellence in Glycosciences, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Biologics and Genetic Therapies Directorate, Health Products and Food Branch, Health Canada, Ottawa, ON, Canada
Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain
Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain
Biologics and Genetic Therapies Directorate, Health Products and Food Branch, Health Canada, Ottawa, ON, Canada
Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain;Instituciò Catalana de Reserca i EstudisAvançats (ICREA), Barcelona, Spain;Centro de Investigación Biomédica en Red de Cancer (CIBER-ONC), Barcelona, Spain
Vol. 104 No. 2 (2019): February, 2019 https://doi.org/10.3324/haematol.2018.196568